DISCOUNT ZERTIFIKAT - BRISTOL-MYERS SQUIBB | Real-time Boerse Frankfurt Warrants 10:45:05 2024-06-19 am EDT | ||
| 35.75 EUR | +0.79% |
|
| Current month | +0.51% | ||
| 1 month | -4.16% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-19 | 35.75 | +0.79% |
| 24-06-18 | 35.47 | -0.98% |
| 24-06-17 | 35.82 | -1.19% |
| 24-06-14 | 36.25 | +0.36% |
| 24-06-13 | 36.12 | -0.99% |
Real-time Boerse Frankfurt Warrants
Last update June 19, 2024 at 10:45 am EDT
More quotesStatic data
| Product type | Certificati Discount |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VM79XS |
| ISIN | DE000VM79XS4 |
| Date issued | 2024-01-10 |
| Maturity | 2024-12-20 (184 Days) |
| Parity | 1 : 1 |
| Emission price | 38.19 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 39.4 € |
|---|---|
| Lowest since issue | 34.87 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.81
USD
Average target price
53.19
USD
Spread / Average Target
+30.35%
- Stock Market
- Certificates
- Certificat
